What AID does

AID Autoimmun Diagnostika GmbH is a German specialty in-vitro diagnostics manufacturer headquartered in Straßberg, Baden-Württemberg, founded in 1988 and operating as a privately held GmbH with 11–50 employees. The company develops and sells diagnostic kits and reader systems for immune monitoring, infectious disease, autoimmune disease, human genetics, and antibiotic resistance testing. Its core technology portfolio spans EliSpot and FluoroSpot assays (single-cell cytokine detection), PCR-based molecular diagnostics, DNA arrays using reverse hybridization, and immunoblots, paired with proprietary reader hardware — including the AID iSpot family, AID vSpot Spectrum, AID multiSpot, AID bacSpot Robot colony counter, and a Scanning System for line probe assays — and the AIDot evaluation software. Disease-specific complete kits (TBSpot, CMVSpot, EBVSpot, LymeSpot, NTM iSpot, HPV DNA Array, ParodontitisPlus) are CE-IVD marked for the European clinical market.\n\nThe company's go-to-market combines a global distributor network covering 12+ European countries, 7+ Asian countries, and 2 Oceanian countries with direct regional sales offices in the USA/Canada and China. Revenue streams span one-time consumable kit sales, hardware sales of reader systems, and service revenue from the Immune Analytics subsidiary, a wholly-owned contract research organization established in 2017 that offers EliSpot/FluoroSpot immunomonitoring for preclinical and clinical studies. Primary end customers are clinical and research laboratories performing immune monitoring, infection diagnostics, genetic testing, and clinical research, with a secondary veterinary laboratory segment. The company does not disclose pricing publicly, does not list named enterprise customers, and has not raised external funding according to the input data.\n\nStrategic positioning centers on integrating proprietary assay chemistry, dedicated reader instrumentation, and evaluation software into closed workflows for specialty diagnostics where CE-IVD clearance and validated protocols create customer stickiness. Distribution is event-driven (MEDLAB, EUROGIN, IVD Symposium, immunology and microbiology conferences) and channel-led, with direct presence only in the two largest addressable markets outside Europe. Ownership remains with the founding Schöllhorn family (Gerlinde and Johannes Schöllhorn as managing directors), and there is no disclosed parent company, external investor, or M&A history.

Name

AID

Legal name

AID Autoimmun Diagnostika GmbH

Website

https://aid-diagnostika.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

11–50 employees

Short description

AID Autoimmun Diagnostika GmbH is a German specialty in-vitro diagnostics company that manufactures EliSpot/FluoroSpot readers, PCR and DNA-array kits, and immunoblots, serving clinical and research laboratories globally through distributors and direct offices in the USA and China.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industry

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Diagnostic immunoassay kits
• EliSpot reader systems
• Molecular diagnostics assays
• Immune monitoring products
• Clinical diagnostic instruments

Headquarters

HQ city

Straßberg

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Diagnostic Kits: Sale of diagnostic assay kits including EliSpot/FluoroSpot kits (T-cell and B-cell assays), molecular biological assay kits (infection diagnostics, human genetics), immunoblots, and DNA/immunoarrays for various diseases and conditions.
2. Reader Systems and Analysis Equipment: Sale and service of automated reader systems (AID iSpot, AID Classic, AID iSpot Spectrum, AID iSpot Robot, AID vSpot, AID multiSpot) for evaluating diagnostic kits. Includes evaluation software AIDot.
3. Contract Research Services (Immune Analytics): CRO services in immunomonitoring through subsidiary Immune Analytics, offering analysis of preclinical and clinical samples using EliSpot and FluoroSpot assays since 2017.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels1 record

Core offering

AID manufactures and distributes diagnostic assay kits and reader/instrument systems used by clinical and research laboratories for immune monitoring and molecular diagnostics. Its portfolio spans EliSpot and FluoroSpot consumables, PCR-based molecular kits for infectious disease and human genetics, DNA and immuno arrays, immunoblots, and the AID reader family (iSpot, Classic, vSpot, multiSpot, bacSpot Colony Counter) paired with AIDot evaluation software. Through its Immune Analytics subsidiary it also offers contract immunomonitoring services.

Product overview

AID Autoimmun Diagnostika GmbH offers a comprehensive portfolio of diagnostic products and laboratory systems for immune monitoring and molecular diagnostics. The product ecosystem centers on two main platforms: (1) Reader Systems including the AID EliSpot Reader family (AID iSpot, iSpot Spectrum, iSpot Robot, Classic), AID vSpot/vSpot Spectrum, AID multiSpot, and AID bacSpot Colony Counter, paired with AIDot AI-powered evaluation software and Scanning Systems for line probe assays; and (2) Diagnostic Kits spanning EliSpot/FluoroSpot assays for T-cell and B-cell immune monitoring (including disease-specific complete kits like CMVSpot, TBSpot, EBVSpot, LymeSpot, NTM iSpot), molecular biological PCR-based assays for infectious diseases (STDs, HPV, respiratory infections, antibiotic resistances) and human genetics (immunology, pharmacogenetics, hematology), plus immunoblot and array products (ImmunoArrays for Borrelia, ANA, EBV; DNA Arrays for HPV). An affiliated CRO, Immune Analytics, provides contract immunomonitoring services.

Differentiator

Problem solved

Functional benefit

Brands

• Immune Analytics: Contract research organization (CRO) offering immunomonitoring services, including EliSpot and FluoroSpot assay analysis for preclinical and clinical samples since 2017.

Products and services

• AID EliSpot Reader family (iSpot, Classic, iSpot Spectrum, iSpot Robot)
• AID vSpot / vSpot Spectrum
• AID multiSpot
• AID bacSpot Robot / AID Colony Counter
• AIDot evaluation software
• Scanning System
• EliSpot and FluoroSpot Assay Kits
• NTM iSpot Complete Kit
• CMVSpot Complete Kit
• TBSpot Complete Kit
• EBVSpot Complete Kit
• LymeSpot Complete Kit
• SARS-CoV-2 Diagnostic Kits
• Molecular Biological Assay Kits (PCR-based)
• ParodontitisPlus PCR Kit
• Human Genetics Assay Kits
• IA3010 Borrelia burgdorferi ImmunoArray
• IA3000 ANA ImmunoArray
• IA3030 EBV ImmunoArray
• DA4270 HPV DNA Array
• Immunoblots
• Immune Analytics Services (CRO)

Quantifiable outcome

• Results for HPV DNA Array within 4 hours
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Qiagen: Qiagen is a global molecular diagnostics leader with broad PCR-based infectious disease, HPV genotyping, and human genetics portfolios. AID's PCR kits, HPV DNA Array, and human genetics line probe assays compete in adjacent segments of Qiagen's offering.
• EUROIMMUN (PerkinElmer): EUROIMMUN, now part of Revvity/PerkinElmer, is a major German autoimmune and infectious disease diagnostics company offering broad immunoassay and autoantibody testing. AID's IA3000 ANA ImmunoArray and EliSpot autoimmune products sit in overlapping clinical categories.
• Hologic: Hologic is a major molecular diagnostics company with strong positions in women's health, including HPV testing on the Panther platform. AID's HPV DNA Array competes in cervical cancer screening workflows alongside Hologic's Aptima HPV assays.
• Becton, Dickinson and Company (BD): BD is a global medical technology company with strong franchises in flow cytometry, immunology reagents, and clinical diagnostics. BD's cellular analysis platforms represent a competitive workflow alternative to AID's EliSpot/FluoroSpot readers.

Direct peers

• Oxford Immunotec: Oxford Immunotec developed the T-SPOT.TB test for tuberculosis diagnosis using an ELISpot-based interferon-gamma release assay. It competes directly with AID's TBSpot and NTM iSpot kits in the cellular TB diagnostics market.
• Cellular Technology Limited (CTL): CTL is a US-based specialist in EliSpot and FluoroSpot immunoassay technologies, offering reader systems, kits, and ImmunoSpot software for immune monitoring. It is the most direct competitor to AID's core T-cell/B-cell diagnostic franchise.
• Mabtech: Mabtech is a Swedish biotechnology company specializing in ELISpot and FluoroSpot kits and readers for cytokine detection. It overlaps directly with AID in T-cell immune monitoring for infectious disease and vaccine research.

Others

• GenID GmbH: GenID GmbH is a German molecular diagnostics company specializing in line probe assays and is referenced as a manufacturing/distribution partner for AID's NTM-iSpot FluoroSpot assay. It operates in an adjacent product space with similar underlying technology.

Regional players

• Mikrogen Diagnostik: Mikrogen Diagnostik is a German IVD company specializing in line probe assays (similar to AID's reverse hybridization arrays), immunoblots, and PCR-based infectious disease diagnostics, including TBEV and Borrelia tests. It is a comparable German-based IVD specialist.

Emerging players

• Lophius Biosciences: Lophius Biosciences is a German biotech developing T-cell-based diagnostics for infectious disease and immune monitoring, including tuberculosis. It targets similar clinical use cases as AID's EliSpot franchise with overlapping immunology assay expertise.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AID